Logo image of EMN.CA

EURO MANGANESE INC (EMN.CA) Stock Fundamental Analysis

TSX-V:EMN - TSX Venture Exchange - CA29872T2092 - Common Stock - Currency: CAD

0.16  -0.01 (-5.88%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EMN. EMN was compared to 797 industry peers in the Metals & Mining industry. EMN may be in some trouble as it scores bad on both profitability and health. EMN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EMN had negative earnings in the past year.
EMN had a negative operating cash flow in the past year.
EMN had negative earnings in each of the past 5 years.
EMN had a negative operating cash flow in each of the past 5 years.
EMN.CA Yearly Net Income VS EBIT VS OCF VS FCFEMN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

EMN's Return On Assets of -57.72% is on the low side compared to the rest of the industry. EMN is outperformed by 66.37% of its industry peers.
Industry RankSector Rank
ROA -57.72%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMN.CA Yearly ROA, ROE, ROICEMN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

EMN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMN.CA Yearly Profit, Operating, Gross MarginsEMN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

2

2. Health

2.1 Basic Checks

EMN does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for EMN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EMN.CA Yearly Shares OutstandingEMN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
EMN.CA Yearly Total Debt VS Total AssetsEMN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -4.20, we must say that EMN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -4.20, EMN is not doing good in the industry: 65.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.2
ROIC/WACCN/A
WACC8.58%
EMN.CA Yearly LT Debt VS Equity VS FCFEMN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

EMN has a Current Ratio of 1.27. This is a normal value and indicates that EMN is financially healthy and should not expect problems in meeting its short term obligations.
EMN's Current ratio of 1.27 is in line compared to the rest of the industry. EMN outperforms 46.17% of its industry peers.
A Quick Ratio of 1.02 indicates that EMN should not have too much problems paying its short term obligations.
EMN's Quick ratio of 1.02 is in line compared to the rest of the industry. EMN outperforms 45.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.02
EMN.CA Yearly Current Assets VS Current LiabilitesEMN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

EMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.81%.
The Revenue has grown by 228.28% in the past year. This is a very strong growth!
EPS 1Y (TTM)-44.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.14%
Revenue 1Y (TTM)228.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMN.CA Yearly Revenue VS EstimatesEMN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 1M 2M 3M
EMN.CA Yearly EPS VS EstimatesEMN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EMN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMN.CA Price Earnings VS Forward Price EarningsEMN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMN.CA Per share dataEMN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EURO MANGANESE INC

TSX-V:EMN (8/7/2025, 7:00:00 PM)

0.16

-0.01 (-5.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-18 2025-08-18
Inst Owners31.11%
Inst Owner ChangeN/A
Ins Owners1.53%
Ins Owner ChangeN/A
Market Cap22.85M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.81
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.03
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.63%
Cap/Sales 86.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.02
Altman-Z -4.2
F-Score3
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)888.95%
Cap/Depr(5y)944.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)228.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.8%
OCF growth 3YN/A
OCF growth 5YN/A